🔴 Citius Pharmaceuticals is trading 6.34% down with no identified company-specific catalyst

Citius Pharmaceuticals is trading at $0.53, down -6.34%, with no fresh company-specific news identified to explain its October 30, 2026 decline.

• The positive LYMPHIR shipment update on October 26 predates the decline and does not establish its cause.
• The recent rally reversed: closes rose from $0.40 on October 23 to $0.56 on October 29.
• Healthcare was reported higher, not lower, so sector weakness does not explain the decline.